Development of a Novel Lipid-Based Nanosystem Functionalized with WGA for Enhanced Intracellular Drug Delivery

Despite a considerable number of new antibiotics under going clinical trials, treatment of intracellular pathogens still represents a major pharmaceutical challenge. The use of lipid nanocarriers provides several advantages such as protection from compound degradation, increased bioavailability, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hädrich, Gabriela, Vaz, Gustavo Richter, Bidone, Juliana, Yurgel, Virginia Campello, Teixeira, Helder Ferreira, Gonçalves Dal Bó, Alexandre, da Silva Pinto, Luciano, Hort, Mariana Appel, Ramos, Daniela Fernandes, Junior, Antonio Sergio Varela, Almeida da Silva, Pedro Eduardo, Dora, Cristiana Lima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611000/
https://www.ncbi.nlm.nih.gov/pubmed/36297456
http://dx.doi.org/10.3390/pharmaceutics14102022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611000/
https://www.ncbi.nlm.nih.gov/pubmed/36297456
http://dx.doi.org/10.3390/pharmaceutics14102022

Ejemplares similares